Search Results for 'patients line'

patients line published presentations and documents on DocSlides.

HIV-1 drug resistance and third-line outcomes among children and adolescents

HIV-1 drug resistance and third-line outcomes among children and adolescents

by lydia

failing second-line therapy . in Malawi. Rachel Ka...

Opioid Concerns in Older Patients

Opioid Concerns in Older Patients

by morton

Alfred Fisher MD PhD. Associate Professor and Chie...

Please note, these are the actual video-recorded proceeding

Please note, these are the actual video-recorded proceeding

by lindy-dunigan

Moderator. Neil Love, MD. Jessica Mitchell, RN, C...

Management of metastatic and recurrent head and neck cancer

Management of metastatic and recurrent head and neck cancer

by liane-varnes

Erin Alesi, MD. Medical Oncology. , Palliative Me...

Treatment-Experienced Patients in Resource-Limited Settings

Treatment-Experienced Patients in Resource-Limited Settings

by pasty-toler

Susan M. Graham . Assistant Professor, Medicine a...

$Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?$

Future directions: Can we improve outcomes in relapsed/refractory DLBCL or aggressive NHL?

by mitsue-stanley

Bertrand Coiffier. Service d. ’. Hématologie. ...

Please note, these are the

Please note, these are the

by disclaimercanon

actual. . video-recorded proceedings from the . l...

by warlikebikers

cancer. , right vs . left. : . how. to take . it....

Clinical considerations for the

Clinical considerations for the

by helene

introduction . of . DTG. Nandita Sugandhi. ICAP at...

AIM Statement The percentage of

AIM Statement The percentage of

by mackenzie

CHFrEF. patients on recommended guideline medical...

CLL: clinical cases Celso Arrais

CLL: clinical cases Celso Arrais

by genevieve

Conflict of Interests. I declare NO relevant confl...

MYCOPHENOLATE MOFETIL FOR FIRST-LINE TREATMENT OF IMMUNE THROMBOCYTOPENIA

MYCOPHENOLATE MOFETIL FOR FIRST-LINE TREATMENT OF IMMUNE THROMBOCYTOPENIA

by taylor

Charlotte A. Bradbury. , . Julie . Pell. Publishe...

Gabor Liposits MD Senior consultant clinical oncologist

Gabor Liposits MD Senior consultant clinical oncologist

by evans

RHG, Herning, Denmark. University of Southern Denm...

Review of Antibiotic Prescribing associated with increased risk of

Review of Antibiotic Prescribing associated with increased risk of

by esther

Clostridium Difficile . prescribed to patients on ...

Recruitment of cancer patients by LCRN

Recruitment of cancer patients by LCRN

by karlyn-bohler

Subspecialty: Haem . Onc. & Lymphoma . Recr...

by olivia-moreira

Glivec. Loyalist. Curer. Glivec. Tasigna. On a P...

by alida-meadow

treatments. in WT . pts. : . which. . opportuni...

Novel Biologic Therapies for

Novel Biologic Therapies for

by olivia-moreira

Second-Line Gastric Cancer. Charles S. Fuchs, MD....

Service Line Strategy Advisor

Service Line Strategy Advisor

by faustina-dinatale

2018 Telehealth Industry Trends. New Advances in ...

Please note, these are the

Please note, these are the

by vizettan

actual. . video-recorded proceedings from the . l...

by dorothy

THE SHORTER MDR-FEATURESOFTHESHORTERMDR-TBREGIMENS...

Central lines in pediatric patients

Central lines in pediatric patients

by everly

Lauren Fortier, NP. Pediatric ICU. Indications. In...

by erica

Fever of Unknown Origin Authors: Patrick Tierney M...

Ward F22 Shared Governance

Ward F22 Shared Governance

by singh

Colleen Allan , Lauren Dennis, Tamsin Oates. . &a...

Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m

Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m

by felicity

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor...

Year in Review — Clinical Investigators Provide Perspectives on the Most Relevant New Publication

Year in Review — Clinical Investigators Provide Perspectives on the Most Relevant New Publication

by obrien

Nontargeted Therapy for Lung Cancer. Tuesday, Janu...

Second line treatments in WT

Second line treatments in WT

by deena

pts. : . which. . opportunities. with . biologic...

Betsy Lee, RN, BSN, MSPH

Betsy Lee, RN, BSN, MSPH

by karlyn-bohler

InAHQ. Spring Conference. May 9, 2014. Making In...

Pilot survey on on-line patient registries

Pilot survey on on-line patient registries

by trish-goza

Go . Yoshizawa. (Osaka University). Background. P...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

by alexa-scheidler

Contemporary Treatment Strategies and Optimal Seq...

Targeting Disease at the Nuclear Pore

Targeting Disease at the Nuclear Pore

by phoebe-click

Corporate Presentation. August 2015. NASDAQ: KPTI...

Update on Follicular Lymphoma:

Update on Follicular Lymphoma:

by tatiana-dople

Contemporary Treatment Strategies and Optimal Seq...

Optimal treatment for elderly patients with NSCLC

Optimal treatment for elderly patients with NSCLC

by cheryl-pisano

Giorgio V. Scagliotti. University. of . Torino,....

Targeting Disease at the Nuclear Pore

Targeting Disease at the Nuclear Pore

by yoshiko-marsland

Corporate Presentation. August 2015. NASDAQ: KPTI...

Shared Decision Making and the Medical Treatment

Shared Decision Making and the Medical Treatment

by lois-ondreau

of Type 2 Diabetes. Speaker’s Disclosure. There...

EGFR-Mutated Advanced NSCLC

EGFR-Mutated Advanced NSCLC

by sherrill-nordquist

The Coming Paradigm Shift. Faculty. Suresh S. Ram...

Renal emergencies MDT teaching Wednesday 11/05/2016

Renal emergencies MDT teaching Wednesday 11/05/2016

by trish-goza

Heartlands Hospital. Dr T cairns. Topics to discu...

Mait Raava Estonian Myeloma Society

Mait Raava Estonian Myeloma Society

by tawny-fly

Copenhagen. , . June 11. th. . 2016. EU Drug App...

B asics of A ntiretroviral

B asics of A ntiretroviral

by yoshiko-marsland

T. herapy (ART) & Management of HIV positive...

Shared Decision Making and the Medical Treatment

Shared Decision Making and the Medical Treatment

by marina-yarberry

of Type 2 Diabetes. Speaker’s Disclosure. There...